| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2883570 | The Annals of Thoracic Surgery | 2006 | 7 Pages |
Abstract
Further studies focusing on the effects of recombinant interleukin-6 in large animal models are warranted, as this may be a novel strategy to improve outcomes after lung transplantation. Intratracheal administration may focus its efficacy on the lung while reducing effects on other organ systems during organ procurement.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Alexander S. MD, Heather E. MD, Mauricio J. MD, Anton S. MRCS, Brendan C. BS, Michael S. MD,